ConductScience.org, home

Paper10469748

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

Rebbeck TR and 14 others. J Natl Cancer Inst, 1999. Cited by 479 papers, by iCite.

Cite this record

ConductScience Library. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Papers, record 10469748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10469748

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
479
iCite
Relative citation ratio, by iCite
11.1
iCite
Revised in PubMed
2022-04-08
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rebbeck TRT R
2Levin AMA M
3Eisen AA
4Snyder CC
5Watson PP
6Cannon-Albright LL
7Isaacs CC
8Olopade OO
9Garber JEJ E
10Godwin AKA K
11Daly MBM B
12Narod SAS A
13Neuhausen SLS L
14Lynch HTH T
15Weber BLB L

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Genes, BRCA1Major topic
MutationMajor topic
OvariectomyMajor topic
Age Factors
Case-Control Studies
Estrogen Replacement Therapy
Female
Heterozygote
Humans
Odds Ratio
Registries
Risk
Surveys and Questionnaires
Time Factors

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA57601NCI NIH HHSUnited StatesR01CA057601PubMed and NIHNIH RePORTER
CA74415NCI NIH HHSUnited StatesR01CA074415PubMed and NIHNIH RePORTER
P30CA16520NCI NIH HHSUnited StatesP30CA016520PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in10469738Bad news/good news: information about breast cancer risk following prophylactic oophorectomy.https://conductscience.org/library/papers/10469738

Source PubMed

Download CSV of comments and corrections

Cited by105

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 479 citations.

PMIDTitleJournalYearIn PapersSource
42130632Hereditary cancer syndromes with gynecological cancer risk: focus on prevention strategies.Front Oncol2026https://conductscience.org/library/papers/42130632PubMed
41811390Impact of Ethnicity on the Uptake of Risk Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.Ann Surg Oncol2026https://conductscience.org/library/papers/41811390PubMed
40243654Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies.Int J Mol Sci2025https://conductscience.org/library/papers/40243654PubMed
40226594Premature ovarian insufficiency and the risk of breast cancer.Hum Reprod Open2025https://conductscience.org/library/papers/40226594PubMed
40025950Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.Cancer Discov2025https://conductscience.org/library/papers/40025950PubMed
38817104Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy.Obstet Gynecol Sci2024https://conductscience.org/library/papers/38817104PubMed
38672070Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery.Biomedicines2024https://conductscience.org/library/papers/38672070PubMed
38112915Contraception as chemoprevention of ovarian cancer in BRCA1 and BRCA2 women.Hormones (Athens)2024https://conductscience.org/library/papers/38112915PubMed
37254150Progesterone from ovulatory menstrual cycles is an important cause of breast cancer.Breast Cancer Res2023https://conductscience.org/library/papers/37254150PubMed
36900415Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis.Cancers (Basel)2023https://conductscience.org/library/papers/36900415PubMed
36637775Hormone replacement therapy in BRCA mutation carriers: how shall we do no harm?Hormones (Athens)2023https://conductscience.org/library/papers/36637775PubMed
36614207The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows.Int J Mol Sci2023https://conductscience.org/library/papers/36614207PubMed
35402908Machine-learning of complex evolutionary signals improves classification of SNVs.NAR Genom Bioinform2022https://conductscience.org/library/papers/35402908PubMed
34348913Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence.Cancer Prev Res (Phila)2021https://conductscience.org/library/papers/34348913PubMed
33885953Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review.J Cancer Res Clin Oncol2021https://conductscience.org/library/papers/33885953PubMed
33010199BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study.J Genet Couns2021https://conductscience.org/library/papers/33010199PubMed
31170278Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire.Genet Mol Biol2019https://conductscience.org/library/papers/31170278PubMed
30883986A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors.Psychooncology2019https://conductscience.org/library/papers/30883986PubMed
30787204Towards a more precise and individualized assessment of breast cancer risk.Aging (Albany NY)2019https://conductscience.org/library/papers/30787204PubMed
30222235Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial.BJOG2019https://conductscience.org/library/papers/30222235PubMed

See all 105 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10469748

GET https://conductscience.org/api/papers/v1/10469748/cited_by?page=2